0001420506-21-000188.txt : 20210210 0001420506-21-000188.hdr.sgml : 20210210 20210210162721 ACCESSION NUMBER: 0001420506-21-000188 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 EFFECTIVENESS DATE: 20210210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC CENTRAL INDEX KEY: 0001020455 IRS NUMBER: 133087622 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05883 FILM NUMBER: 21614240 BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127516677 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: RHO MANAGEMENT CO INC DATE OF NAME CHANGE: 19960806 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001020455 XXXXXXXX 12-31-2020 12-31-2020 false RHO CAPITAL PARTNERS INC

152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019

13F HOLDINGS REPORT 028-05883 N Peter E. Kalkanis 2127516677 Peter E. Kalkanis, Chief Financial Officer NEW YORK NY 02-08-2021 0 5 190009 false INFORMATION TABLE 2 Form13F_InfoTable.xml INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC CARA THERAPEUTICS INC COM 140755109 42350 2799058 SH SOLE 2799058 0 0 LIVEXLIVE MEDIA INC COM NEW 53839L208 12215 3724138 SH SOLE 3724138 0 0 MERSANA THERAPEUTICS INC COM 59045L106 21194 796458 SH SOLE 796458 0 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 114111 3766666 SH SOLE 3766666 0 0 SENSEONICS HLDGS INC COM 81727U105 139 159601 SH SOLE 159601 0 0